Indo US Bio-Tech (BOM:541304) EV-to-EBIT : 22.65 (As of Jul. 05, 2025)

Indo US Bio-Tech EV-to-EBIT Chart

Indo US Bio-Tech Annual Data
	Trend	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25
EV-to-EBIT		Get a 7-Day Free Trial					6.17	11.57	26.38	44.44	17.20

Indo US Bio-Tech Quarterly Data
	Oct17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Jun22	Sep22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															51.26	44.44	59.99	56.25	17.20

Competitive Comparison of Indo US Bio-Tech's EV-to-EBIT

For the Agricultural Inputs subindustry, Indo US Bio-Tech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indo US Bio-Tech's EV-to-EBIT Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's EV-to-EBIT falls into.

Indo US Bio-Tech EV-to-EBIT Calculation

Indo US Bio-Tech's EV-to-EBIT for today is calculated as:

Indo US Bio-Tech's current Enterprise Value is ₹3,285.0 Mil.
Indo US Bio-Tech's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹145.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech  (BOM:541304) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Indo US Bio-Tech's Enterprise Value for the quarter that ended in Mar. 2025 was ₹3,098.5 Mil.
Indo US Bio-Tech's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹145.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo US Bio-Tech Business Description